P4‐437: Repeated baseline cognitive measurements in mild to moderate AD patients reveal significant day‐to‐day variation
Year: 2011
Type: article
Source: Alzheimer s & Dementia
Institutions: AstraZeneca (Sweden), AstraZeneca (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2105884546
